WASHINGTON, Oct. 14, 2025 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. NASDAQ: ASPI ("ASP Isotopes” or the “Company”), an advanced materials company dedicated to the development of technology and processes for the production of isotopes for use in multiple industries, today announced that it is commencing an underwritten public offering of shares of its common stock. The offering is subject to market conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual ...

Core Viewpoint - ASP Isotopes Inc. has announced a registered direct offering of 7,500,000 shares at $8.00 per share, aiming to raise approximately $60.0 million in gross proceeds [1][2]. Group 1: Offering Details - The offering is expected to close on or about July 25, 2025, pending customary closing conditions [1]. - Cantor and Canaccord Genuity are acting as joint book-running managers, while Ocean Wall Limited serves as the financial advisor for the offering [2]. - The net proceeds will be utilized for general corporate purposes, including working capital, operating expenses, and capital expenditures [2]. Group 2: Company Overview - ASP Isotopes Inc. is a development stage advanced materials company focused on producing isotopes for various industries, employing proprietary Aerodynamic Separation Process (ASP technology) [5]. - The company aims to produce highly enriched isotopes for healthcare and technology sectors, and plans to enrich isotopes for the nuclear energy sector using Quantum Enrichment technology [5]. - The company has isotope enrichment facilities located in Pretoria, South Africa, dedicated to enriching light isotopes [5]. Group 3: Market Demand - There is an increasing demand for isotopes such as Silicon-28 for quantum computing and various isotopes for emerging healthcare applications and green energy applications [6]. - The ASP technology is particularly suitable for enriching both low and heavy atomic mass molecules, aligning with the growing market needs [6].